{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:22:54Z","timestamp":1787844174531,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>AIM:<\/jats:title>\n                    <jats:p>The aim of the study was to demonstrate that ID-NAT is more sensitive and specific in HCV detection in dialysis patients than serological tests such as chemiluminescence. Second, to establish that ID-NAT results are more in concordance to gold standard RT-PCR compared to chemiluminescence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHOD:<\/jats:title>\n                    <jats:p>A prospective observational single center study conducted in the Department of Transfusion Medicine and Immunohematology and Department of Nephrology, Indraprastha Apollo Hospital, New Delhi from September 2020 to December 2022. The blood samples from patients within inclusion criteria were run with chemiluminescence, ID-NAT and RT-PCR. Results were analyzed to determine the association between categorical variables and Cohen kappa values, to show the concordance between the gold standard and the ID-NAT and RT-PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The total number of subjects who participated in the study was n = 145 and were all Indians from neighboring states near to the institution. As reflected in the study results, among the 130 non-reactive results in CMIA, PCR showed 127 negative and 3 positive results. In similar manner, among 15 reactive results in CMIA, 13 were positive and 2 were negative in PCR (p value 0.001). In the present study, it was revealed that among the 129 non-reactive results in ID-NAT, 129 were negative in PCR (P value &lt;0.001). Prevalence of HCV among patients with ID-NAT was 11.03% (CI = 6.44% to 17.30%). Similarly, the agreement of chemiluminescence with RT-PCR revealed kappa value = 0.819, whereas ID-NAT showed kappa value = 1, thus showing superior concordance to said gold standard.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The study results confirm that ID-NAT is a more efficient and reliable test method compared to serological tests such as chemiluminescence in detecting HCV cases in immunosilent cases or cases in the immune period.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_211_24","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:02:22Z","timestamp":1770199342000},"page":"156-163","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of diagnostic performance of transcription-mediated amplification with chemiluminescent microparticle immunoassay in the detection of hepatitis C virus in dialysis patient group"],"prefix":"10.4103","volume":"20","author":[{"given":"Sourav","family":"Chowdhury","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, Apollo Multispeciality Hospitals, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Chowdhry","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine and Immunology, Indraprastha Apollo, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Indraprastha Apollo, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Jasuja","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Indraprastha Apollo, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"R1-20260529","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"R2-20260529","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199111073251901","article-title":"hepatitis C virus infection in post-transfusion hepatitis","volume":"325","author":"Aach","year":"1991","journal-title":"N Engl J Med"},{"key":"R3-20260529","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.7.4.505","article-title":"Hepatitis C:Progress and problems","volume":"7","author":"Cuthbert","year":"1994","journal-title":"Clin Microbiol Rev"},{"key":"R4-20260529","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4254\/wjh.v7.i6.885","article-title":"Hepatitis C infection in hemodialysis patients:A review","volume":"7","author":"Etik","year":"2015","journal-title":"WJH"},{"key":"R5-20260529","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/jlts.2003.50244","article-title":"Scope of worldwide hepatitis C problem","volume":"9","author":"Brown","year":"2003","journal-title":"Liver Transpl"},{"key":"R6-20260529","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1099\/0022-1317-76-3-711","article-title":"Diversity of genotypes of hepatitis C virus in Southern India","volume":"76","author":"Valliammai","year":"1995","journal-title":"J Gen Virol"},{"key":"R7-20260529","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1096-9071(199602)48:2<191::AID-JMV12>3.0.CO;2-I","article-title":"Genotype determination of hepatitis C virus from Northern India:Identification of a new subtype","volume":"48","author":"Panigrahi","year":"1996","journal-title":"J Med Virol"},{"key":"R8-20260529","first-page":"1139","article-title":"Hepatitis C virus infection during haemodialysis in India","volume":"47","author":"Agarwal","year":"1999","journal-title":"J Assoc Physicians India"},{"key":"R9-20260529","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0971-4065.53324","article-title":"Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital","volume":"19","author":"Jasuja","year":"2009","journal-title":"Indian J Nephrol"},{"key":"R10-20260529","doi-asserted-by":"crossref","first-page":"c133","DOI":"10.1159\/000191208","article-title":"Hepatitis C virus infection in haemodialysis:The 'no-isolation'policy should not be generalized","volume":"111","author":"Agarwal","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"R11-20260529","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3109\/0886022X.2010.486499","article-title":"Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis population","volume":"32","author":"Rao","year":"2010","journal-title":"Ren Fail"},{"key":"R12-20260529","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0973-6247.126683","article-title":"Hepatitis C virus:Screening, diagnosis, and interpretation of laboratory assays","volume":"8","author":"Gupta","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"R13-20260529","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3748\/wjg.v20.i11.2948","article-title":"Current testing strategies for hepatitis C virus infection in blood donors and the way forward","volume":"20","author":"Marwaha","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R14-20260529","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/jcm.31.11.2913-2917.1993","article-title":"Virological features of hepatitis C virus infection in hemodialysis patients","volume":"31","author":"Silini","year":"1993","journal-title":"J Clin Microbiol"},{"key":"R15-20260529","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1128\/JCM.36.6.1711-1715.1998","article-title":"Hepatitis C virus infections in dialysis centers in The Netherlands:A national survey by serological and molecular methods","volume":"36","author":"Schneeberger","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R17-20260529","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gut.51.3.429","article-title":"Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients:A multicentre study in 2796 patients","volume":"51","author":"Hinrichsen","year":"2002","journal-title":"Gut"},{"key":"R18-20260529","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jcv.2005.05.007","article-title":"HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis:Results from five hemodialysis units in central Greece","volume":"34","author":"Rigopoulou","year":"2005","journal-title":"J Clin Virol"},{"key":"R20-20260529","first-page":"4","article-title":"Evaluation of assay methods and false positive results in the laboratory diagnosis of hepatitis C virus infection","volume":"2","author":"Kesli","year":"2011","journal-title":"Arch Clin Microbiol"},{"key":"R21-20260529","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3343\/alm.2018.38.5.466","article-title":"The role of the signal-to-cutoff ratio in automated anti-HCV chemiluminescent immunoassays by referring to the nucleic acid amplification test and the recombinant immunoblot assay","volume":"38","author":"Choi","year":"2018","journal-title":"Ann Lab Med"},{"key":"R22-20260529","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1053\/j.ajkd.2005.05.006","article-title":"Diagnostic discordance for hepatitis C virus infection in hemodialysis patients","volume":"46","author":"Kalantar-Zadeh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R23-20260529","first-page":"207","article-title":"Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital","volume":"25","author":"Chatterjee","year":"2012","journal-title":"Natl Med J India"},{"key":"R24-20260529","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int J Med Sci"},{"key":"R25-20260529","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1601-0825.2007.01419.x","article-title":"Hepatitis C:A clinical review:Hepatitis C:A clinical review","volume":"14","author":"Modi","year":"2007","journal-title":"Oral Dis"},{"key":"R26-20260529","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.kint.2018.11.038","article-title":"Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients","volume":"95","author":"Jadoul","year":"2019","journal-title":"Kidney Int"},{"key":"R27-20260529","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0272-6386(12)80931-0","article-title":"Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients","volume":"22","author":"Dussol","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R28-20260529","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6275987","article-title":"Potential hepatoprotective role of galectin-3 during HCV infection in end-stage renal disease patients","volume":"2017","author":"Lukic","year":"2017","journal-title":"Dis Markers"},{"key":"R29-20260529","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000319456","article-title":"Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis","volume":"32","author":"Noureddine","year":"2010","journal-title":"Am J Nephrol"},{"key":"R30-20260529","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents:The DOPPS","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int"},{"key":"R31-20260529","article-title":"Abbott Laboratories","year":"2009"},{"key":"R32-20260529","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C:An update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"R33-20260529","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1542-4758.2011.00662.x","article-title":"High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis:False-negative anti-HCV in HD patients","volume":"16","author":"El-Sherif","year":"2012","journal-title":"Hemodial Int"},{"key":"R36-20260529","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12985-016-0478-6","article-title":"The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia","volume":"13","author":"Tsertsvadze","year":"2016","journal-title":"Virol J"},{"key":"R37-20260529","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1537-2995.2010.02622.x","article-title":"Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing:HIV and HCV infections among us blood donors","volume":"50","author":"Zou","year":"2010","journal-title":"Transfusion"},{"key":"R39-20260529","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/tme.12923","article-title":"Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield\/window period model in an Indian setting","volume":"32","author":"Pandey","year":"2022","journal-title":"Transfus Med"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_211_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:12:54Z","timestamp":1787843574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_211_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_211_24","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2024-12-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}